One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study.

One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study.

<h4>Purpose</h4>We evaluated the IOP-lowering efficacy and safety of latanoprostene bunod (LBN) ophthalmic solution 0.024% (Vyzulta®), the first topical nitric oxide-donating prostaglandin analog (PGA), in clinical practice.<h4>Materials and methods</h4>A retrospective medica...

Full description

Saved in:
Bibliographic Details
Main Authors: Chun-Mei Hsueh, Chen-Hsin Tsai, Jou-Chen Huang, Si-Huei Lee, Tsung-Jen Wang, Siao-Pei Guo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0307132
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items